Vaccines against Influenza A (H1N1) Pandemic

被引:11
|
作者
Luis Valdespino-Gomez, Jose [2 ]
Garcia-Garcia, Lourdes [1 ]
Ponce de Leon-Rosales, Samuel [2 ]
机构
[1] INSP, Cuernavaca 62508, Morelos, Mexico
[2] Lab Biol & React Mexico BIRMEX, Mexico City, DF, Mexico
关键词
Vaccines; Influenza A (H1N1); IMMUNIZATION; ANTIBODIES; SQUALENE; ILLNESS; MOTHER;
D O I
10.1016/j.arcmed.2009.10.008
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background and Aims. The World Health Organization (WHO) has reported, as of September 2009, that the influenza A (H1N1) influenza pandemic has originated >300,000 laboratory-confirmed cases and 3917 deaths in 191 countries. It is recognized that pandemic vaccines have their greatest impact as a preventive strategy when administered before or near the peak incidence of cases in an outbreak. Therefore, vaccination campaigns should be in place when influenza A (H1N1) 2009 vaccines are available. We undertook this study to provide updated information on clinical evaluation of influenza A (H I NI) vaccines and review recommendations for influenza A (H1N1) vaccination campaigns and public health policy. Methods. The following methods were used: 1) review of registry at ClinicalTrials.gov. 2) search of PubMed Central (PMC) for influenza A (HIND vaccine. 3) review of recommendations of WHO, Mexican Health Secretariat (SSA) and Advisory Committee on Immunization Practices (ACIP) on influenza A (H1N1) vaccination campaigns. Results. Until October 1, 2009 there were 11 available influenza A (H1N1) candidate strains provided by WHO Global Influenza Surveillance Network. ClinicalTrials.gov registers 45 phase I and II clinical trials evaluating immunogenicity and safety of influenza A (H1N1) vaccines. Preliminary results support administration of a single dose and use of adjuvants. Main recommendations of WHO, SSA and ACIP include epidemiologic considerations, objectives, definition of target groups and reinforcement of other mitigation measures. Conclusions. The present pandemic of influenza A (HIND has shown mild to moderate severity. Vaccination strategies in Mexico will have the objective of decreasing severe outcomes, slowing transmission, protecting groups at increased risk of infection, complications, or death, and preventing overload of health services. Control of the pandemic should include reinforcement of other non-pharmacologic measures of mitigation and, importantly, an adequate strategy of social communication. (C) 2009 IMSS. Published by Elsevier Inc.
引用
收藏
页码:693 / 704
页数:12
相关论文
共 50 条
  • [1] Unlicensed pandemic influenza A H1N1 vaccines
    Caplan, Arthur L.
    LANCET, 2010, 375 (9713): : 444 - 445
  • [2] Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets
    Stittelaar, Koert J.
    Kroeze, Edwin J. B. Veldhuis
    Rudenko, Larisa
    Dhere, Rajeev
    Thirapakpoomanunt, Sit
    Kieny, Marie Paule
    Osterhaus, Albert D. M. E.
    VACCINE, 2011, 29 (49) : 9265 - 9270
  • [3] Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge
    Yang, Huanliang
    Chen, Yan
    Shi, Jianzhong
    Guo, Jing
    Xin, Xiaoguang
    Zhang, Jian
    Wang, Dayan
    Shu, Yuelong
    Qiao, Chuanling
    Chen, Hualan
    VETERINARY MICROBIOLOGY, 2011, 152 (3-4) : 229 - 234
  • [4] Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines
    DeStefano, Frank
    Vellozzi, Claudia
    Schonberger, Lawrence B.
    Chen, Robert T.
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [5] PANDEMIC INFLUENZA A(H1N1) 2009 VACCINES IN THE EUROPEAN UNION
    Johansen, K.
    Nicoll, A.
    Ciancio, B. C.
    Kramarz, P.
    EUROSURVEILLANCE, 2009, 14 (41): : 12 - 18
  • [6] Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance
    Kurz, Xavier
    Domergue, Francois
    Slattery, Jim
    Segec, Andrej
    Szmigiel, Agnieszka
    Hidalgo-Simon, Ana
    VACCINE, 2011, 29 (26) : 4378 - 4387
  • [7] Pandemic Influenza A (H1N1)
    Sharon, Bazak
    Schleiss, Mark R.
    PEDIATRIC RESEARCH, 2009, 66 (06) : 599 - 599
  • [8] Pandemic H1N1 influenza
    Wiwanitkit, Viroj
    SAUDI MEDICAL JOURNAL, 2010, 31 (12) : 1380 - 1380
  • [9] Pandemic Influenza A (H1N1)
    Bazak Sharon
    Mark R Schleiss
    Pediatric Research, 2009, 66 : 599 - 599
  • [10] Influenza virus vaccines: lessons from the 2009 H1N1 pandemic
    Broadbent, Andrew J.
    Subbarao, Kanta
    CURRENT OPINION IN VIROLOGY, 2011, 1 (04) : 254 - 262